PuSH - Publikationsserver des Helmholtz Zentrums München

Yang, W.* ; Cintina, I.* ; Hoerger, T.* ; Neuwahl, S.J.* ; Shao, H.* ; Laxy, M. ; Zhang, P.*

Estimating costs of diabetes complications in people <65 years in the U.S. using panel data.

J. Diab. Complic. 34:107735 (2020)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Aims: To estimate the cost of diabetes complications in the United States (U.S.). Methods: We constructed longitudinal panel data using one of the largest claims databases in the U.S. for privately insured Type 1 (T1DM) and type 2 (T2DM) diabetes patients with a follow-up time of one to ten years. Complication costs were estimated both in years of the first occurrence and in subsequent years, using individual fixed-effects models. All costs were in 2016 dollars. Results: 47,166 people with T1DM and 608,237 with T2DM were included in our study. Aside from organ transplants, which were rare, the estimated average costs for the top three most costly conditions in the first vs. subsequent years were: end stage renal disease ($73,534 vs. $97,431 for T1DM; $94,231 vs. $98,981 for T2DM), congestive heart failure ($41,681 vs. $14,855 for T1DM; $31,202 vs. $7062 for T2DM), and myocardial infarction ($40,899 vs. $9496 for T1DM; $45,251 vs. $8572 for T2DM). For both diabetes types, retinopathy and neuropathy tend to have the lowest cost estimates. Conclusions: Our study provides the latest and most comprehensive cost estimates for a broad set of diabetes complications needed to evaluate the long-term cost-effectiveness of interventions for preventing and managing diabetes.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Complications ; Costs ; Diabetes; Direct Medical Costs; Health-care Costs; Type-2
ISSN (print) / ISBN 1056-8727
e-ISSN 1056-8727
Quellenangaben Band: 34, Heft: 12, Seiten: , Artikelnummer: 107735 Supplement: ,
Verlag Elsevier
Verlagsort Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Förderungen Type 2 Diabetes Computer Simulation Modeling project by RTI International under Centers for Disease Control and Prevention
Type 1 Diabetes Computer Simulation Modeling project by RTI International under Centers for Disease Control and Prevention